Last reviewed · How we verify

NCT02671240: PROBA-PD

Prognosis of Behavioral Addiction in Parkinson's Disease

Terminated Last updated 23 August 2023
What this trial tests

trial in Addiction in 164 participants. Terminated before completion.

Timeline
24 October 2016
Primary endpoint
19 April 2019
19 April 2019

Quick facts

Lead sponsorUniversity Hospital, Strasbourg, France
StatusTerminated
Study typeOBSERVATIONAL
Enrollment164
Start date24 October 2016
Primary completion19 April 2019
Estimated completion19 April 2019
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Strasbourg, France

Who can join

30 and older, any sex, with Addiction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our hypothesis is that the conventional treatment of Behavioral Addiction in Parkinson's disease is often not effective, and that affects the motor aspects (worsening akinéto-rigid syndrome and / or worsening of dyskinesia due to higher levodopa doses to compensate for the drop in behavioral addictions) and non-motor (withdrawal syndrome dopamine agonist) anxiously including apathy. Our goal is to describe the natural history of Behavioral Addiction under the effect of the evolution of the disease and adapt treatment according to the prior art, through a study of a larger population of patients than in the few published studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Addiction

Currently open trials in the same condition.

Other University Hospital, Strasbourg, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02671240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing